Atossa Therapeutics, Inc.
ATOS · NASDAQ
Bulios Fair Price
$1.7
24.4% downside
Trenutna cena
$2.25
Po podatkih Bulios Fair Price je delnica ATOS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Atossa Therapeutics, Inc. (ATOS) is a biotechnology company focused on the development and commercialization of drugs and therapies in the fields of oncology and women's health. The company concentrates on researching new medications and diagnostic methods aimed at the prevention and treatment of various types of cancer, including breast cancer. Atossa Therapeutics also develops innovative treatments and therapeutic approaches to enhance women's health. Shares of Atossa Therapeutics, Inc. (ATOS) can be an interesting choice for investors tracking the biotechnology sector and the development of drugs and therapies.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Steven C. Quay
Employees
16
Headquarters
Seattle
Prihajajoči dogodki
Earnings
Upcoming earnings report